Yuan Detian, Huang Shan, Berger Emanuel, Liu Lei, Gross Nina, Heinzmann Florian, Ringelhan Marc, Connor Tracy O, Stadler Mira, Meister Michael, Weber Julia, Öllinger Rupert, Simonavicius Nicole, Reisinger Florian, Hartmann Daniel, Meyer Rüdiger, Reich Maria, Seehawer Marco, Leone Valentina, Höchst Bastian, Wohlleber Dirk, Jörs Simone, Prinz Marco, Spalding Duncan, Protzer Ulrike, Luedde Tom, Terracciano Luigi, Matter Matthias, Longerich Thomas, Knolle Percy, Ried Thomas, Keitel Verena, Geisler Fabian, Unger Kristian, Cinnamon Einat, Pikarsky Eli, Hüser Norbert, Davis Roger J, Tschaharganeh Darjus F, Rad Roland, Weber Achim, Zender Lars, Haller Dirk, Heikenwalder Mathias
Institute of Virology, Technische Universität München and Helmholtz Zentrum München, 81675 Munich, Germany; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Cancer Cell. 2017 Jun 12;31(6):771-789.e6. doi: 10.1016/j.ccell.2017.05.006.
Intrahepatic cholangiocarcinoma (ICC) is a highly malignant, heterogeneous cancer with poor treatment options. We found that mitochondrial dysfunction and oxidative stress trigger a niche favoring cholangiocellular overgrowth and tumorigenesis. Liver damage, reactive oxygen species (ROS) and paracrine tumor necrosis factor (Tnf) from Kupffer cells caused JNK-mediated cholangiocellular proliferation and oncogenic transformation. Anti-oxidant treatment, Kupffer cell depletion, Tnfr1 deletion, or JNK inhibition reduced cholangiocellular pre-neoplastic lesions. Liver-specific JNK1/2 deletion led to tumor reduction and enhanced survival in Akt/Notch- or p53/Kras-induced ICC models. In human ICC, high Tnf expression near ICC lesions, cholangiocellular JNK-phosphorylation, and ROS accumulation in surrounding hepatocytes are present. Thus, Kupffer cell-derived Tnf favors cholangiocellular proliferation/differentiation and carcinogenesis. Targeting the ROS/Tnf/JNK axis may provide opportunities for ICC therapy.
肝内胆管癌(ICC)是一种恶性程度高、异质性强且治疗选择有限的癌症。我们发现线粒体功能障碍和氧化应激会引发一种有利于胆管细胞过度生长和肿瘤发生的微环境。肝脏损伤、库普弗细胞产生的活性氧(ROS)和旁分泌肿瘤坏死因子(Tnf)导致JNK介导的胆管细胞增殖和致癌转化。抗氧化治疗、库普弗细胞清除、Tnfr1缺失或JNK抑制可减少胆管细胞的癌前病变。在Akt/Notch或p53/Kras诱导的ICC模型中,肝脏特异性JNK1/2缺失导致肿瘤缩小并提高生存率。在人类ICC中,ICC病变附近Tnf高表达、胆管细胞JNK磷酸化以及周围肝细胞中ROS积累均有出现。因此,库普弗细胞衍生的Tnf有利于胆管细胞增殖/分化和致癌作用。靶向ROS/Tnf/JNK轴可能为ICC治疗提供机会。